Business

Boston Business Journal Report: Sanofi to Buy Bioverativ for $11.6B

•

Biotech and higher education reporter Max Stendahl joins necn to discuss his story, "Sanofi to buy Bioverativ, Biogen's hemophilia spinout, for $11.6B."

Local Connecticut Maine Massachusetts New Hampshire Rhode Island Vermont Weather Maps & Radar Weather Alerts School Closing Alerts NBC Sports Boston Traffic Politics New Hampshire Primary Business US & World
TV Listings Submit Photos and Video Newsletters Our Apps Cozi TV
Contact Us